How Do 5-Alpha-Reductase Inhibitors Change PSA Density in Patients on Active Surveillance?
April 2024
in “
The Journal of urology/The journal of urology
”
Studysummary This study observed that although 5-alpha-reductase inhibitors reduce PSA density in patients on active surveillance for prostate cancer, those who progress to more serious disease still show higher PSA densities, suggesting these inhibitors accentuate differences in clinically significant cases.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on auajournals.org →